Steeplechase Cancer Center is a clinical research site located in Somerville, New Jersey, United States 08876.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
Steeplechase Cancer Center has participated in 4 clinical trials with 2 currently active.
Therapeutic areas: Multiple Myeloma, Chronic Lymphocytic Leukemia, HER2 Positive Breast Cancer.
Sponsors: Celgene, Seagen, a wholly owned subsidiary of Pfizer, Rutgers, The State University of New Jersey.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Somerville
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Steeplechase Cancer Center has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Steeplechase Cancer Center has 4 clinical trials on record, with 2 currently active. Their work covers Multiple Myeloma, Chronic Lymphocytic Leukemia, HER2 Positive Breast Cancer.
Steeplechase Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.